
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Revenue | $4.4B | $6.3B | $8.1B | $9.6B | $10.6B | |
Revenue Growth (YoY) | 10.62% | 42.14% | 29.63% | 18.6% | 10.07% | |
Cost of Revenues | $1.9B | $2.6B | $3.6B | $4B | $4.3B | |
Gross Profit | $2.5B | $3.6B | $4.5B | $5.6B | $6.3B | |
Gross Profit Margin | 55.98% | 57.68% | 55.39% | 58.31% | 59.23% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.6B | $2.2B | $2.8B | $3.4B | $3.8B | |
Other Inc / (Exp) | -$30.5M | -$40.9M | -$393.6M | -$31.4M | $70.4M | |
Operating Expenses | $1.6B | $2.2B | $2.8B | $3.4B | $3.8B | |
Operating Income | $849.8M | $1.4B | $1.7B | $2.2B | $2.5B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $819.4M | $1.3B | $1.3B | $2.2B | $2.6B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $230.4M | $358.5M | $477.8M | $625.5M | $761.5M | |
Net Income to Company | $588.9M | $975.3M | $854.8M | $1.6B | $1.8B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $588.9M | $975.3M | $854.8M | $1.6B | $1.8B | |
Basic EPS (Cont. Ops) | $4.52 | $7.52 | $6.70 | $12.23 | $14.67 | |
Diluted EPS (Cont. Ops) | $4.50 | $7.49 | $6.68 | $12.20 | $14.64 | |
Weighted Average Basic Share | $130.3M | $129.8M | $127.7M | $126.7M | $123.7M | |
Weighted Average Diluted Share | $130.9M | $130.3M | $128M | $127.1M | $123.9M | |
EBITDA | $1B | $1.6B | $2B | $2.6B | $3B | |
EBIT | $849.8M | $1.4B | $1.7B | $2.2B | $2.5B | |
Revenue (Reported) | $4.4B | $6.3B | $8.1B | $9.6B | $10.6B | |
Operating Income (Reported) | $849.8M | $1.4B | $1.7B | $2.2B | $2.5B | |
Operating Income (Adjusted) | $849.8M | $1.4B | $1.7B | $2.2B | $2.5B |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.6B | $2B | $2.2B | $2.4B | |
Revenue Growth (YoY) | 88.12% | 31.55% | 24.01% | 10.4% | 7.32% | |
Cost of Revenues | $526.2M | $743.1M | $850M | $933.8M | $987.5M | |
Gross Profit | $700.3M | $870.4M | $1.2B | $1.3B | $1.4B | |
Gross Profit Margin | 57.1% | 53.95% | 57.52% | 57.72% | 58.34% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $496.6M | $607.9M | $747.5M | $842.4M | $942.9M | |
Other Inc / (Exp) | -$7.4M | -$22K | $8M | $23.3M | $11.8M | |
Operating Expenses | $498.8M | $610M | $749.4M | $842.4M | $944.5M | |
Operating Income | $201.5M | $260.3M | $401.4M | $432.6M | $438.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $194M | $260.3M | $409.4M | $455.9M | $450.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $49.1M | $70.3M | $119M | $134.5M | $135.8M | |
Net Income to Company | $145M | $190M | $290.4M | $321.4M | $314.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $145M | $190M | $290.4M | $321.4M | $314.6M | |
Basic EPS (Cont. Ops) | $1.11 | $1.48 | $2.28 | $2.55 | $2.61 | |
Diluted EPS (Cont. Ops) | $1.11 | $1.48 | $2.28 | $2.54 | $2.60 | |
Weighted Average Basic Share | $130.4M | $128.1M | $127.2M | $126M | $120.6M | |
Weighted Average Diluted Share | $131M | $128.5M | $127.6M | $126.3M | $120.8M | |
EBITDA | $252M | $324.8M | $485.5M | $528.4M | $553.2M | |
EBIT | $201.5M | $260.3M | $401.4M | $432.6M | $438.6M | |
Revenue (Reported) | $1.2B | $1.6B | $2B | $2.2B | $2.4B | |
Operating Income (Reported) | $201.5M | $260.3M | $401.4M | $432.6M | $438.6M | |
Operating Income (Adjusted) | $201.5M | $260.3M | $401.4M | $432.6M | $438.6M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $5B | $6.6B | $8.5B | $9.8B | $10.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.1B | $2.9B | $3.7B | $4.1B | $4.4B | |
Gross Profit | $2.8B | $3.8B | $4.8B | $5.7B | $6.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.8B | $2.3B | $2.9B | $3.5B | $3.9B | |
Other Inc / (Exp) | -$37M | -$33.5M | -$385.5M | -$16.2M | $58.9M | |
Operating Expenses | $1.8B | $2.3B | $2.9B | $3.5B | $3.9B | |
Operating Income | $1B | $1.4B | $1.9B | $2.2B | $2.5B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $979.5M | $1.4B | $1.5B | $2.2B | $2.6B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $274.2M | $379.8M | $526.5M | $641M | $762.8M | |
Net Income to Company | $705.2M | $1B | $955.2M | $1.6B | $1.8B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $705.2M | $1B | $955.2M | $1.6B | $1.8B | |
Basic EPS (Cont. Ops) | $5.41 | $7.90 | $7.49 | $12.50 | $14.78 | |
Diluted EPS (Cont. Ops) | $5.39 | $7.87 | $7.48 | $12.46 | $14.76 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.2B | $1.7B | $2.2B | $2.6B | $3B | |
EBIT | $1B | $1.4B | $1.9B | $2.2B | $2.5B | |
Revenue (Reported) | $5B | $6.6B | $8.5B | $9.8B | $10.7B | |
Operating Income (Reported) | $1B | $1.4B | $1.9B | $2.2B | $2.5B | |
Operating Income (Adjusted) | $1B | $1.4B | $1.9B | $2.2B | $2.5B |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.6B | $2B | $2.2B | $2.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $526.2M | $743.1M | $850M | $933.8M | $987.5M | |
Gross Profit | $700.3M | $870.4M | $1.2B | $1.3B | $1.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $496.6M | $607.9M | $747.5M | $842.4M | $942.9M | |
Other Inc / (Exp) | -$7.4M | -$22K | $8M | $23.3M | $11.8M | |
Operating Expenses | $498.8M | $610M | $749.4M | $842.4M | $944.5M | |
Operating Income | $201.5M | $260.3M | $401.4M | $432.6M | $438.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $194M | $260.3M | $409.4M | $455.9M | $450.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $49.1M | $70.3M | $119M | $134.5M | $135.8M | |
Net Income to Company | $145M | $190M | $290.4M | $321.4M | $314.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $145M | $190M | $290.4M | $321.4M | $314.6M | |
Basic EPS (Cont. Ops) | $1.11 | $1.48 | $2.28 | $2.55 | $2.61 | |
Diluted EPS (Cont. Ops) | $1.11 | $1.48 | $2.28 | $2.54 | $2.60 | |
Weighted Average Basic Share | $130.4M | $128.1M | $127.2M | $126M | $120.6M | |
Weighted Average Diluted Share | $131M | $128.5M | $127.6M | $126.3M | $120.8M | |
EBITDA | $252M | $324.8M | $485.5M | $528.4M | $553.2M | |
EBIT | $201.5M | $260.3M | $401.4M | $432.6M | $438.6M | |
Revenue (Reported) | $1.2B | $1.6B | $2B | $2.2B | $2.4B | |
Operating Income (Reported) | $201.5M | $260.3M | $401.4M | $432.6M | $438.6M | |
Operating Income (Adjusted) | $201.5M | $260.3M | $401.4M | $432.6M | $438.6M |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.2B | $1.3B | $1.2B | $2.2B | $2B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $62.4M | $77M | $132.9M | $124.8M | $120.2M | |
Inventory | $647.2M | $966.5M | $1.4B | $1.3B | $1.4B | |
Prepaid Expenses | $82.2M | $140.9M | $142M | $137.2M | $147.7M | |
Other Current Assets | $25.6M | $32.6M | $80M | $46.7M | $26.9M | |
Total Current Assets | $2.1B | $2.6B | $3.2B | $4.1B | $4B | |
Property Plant And Equipment | $1.5B | $1.7B | $2.2B | $2.8B | $3.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $386.9M | $386.9M | $24.1M | $24.1M | $159.5M | |
Other Intangibles | $80.1M | $71.3M | $22M | -- | $11.7M | |
Other Long-Term Assets | $83.5M | $108M | $127.6M | $154.9M | $193.8M | |
Total Assets | $4.2B | $4.9B | $5.6B | $7.1B | $7.6B | |
Accounts Payable | $172.2M | $289.7M | $172.7M | $348.4M | $271.4M | |
Accrued Expenses | $146.9M | $240.3M | $284.1M | $258.7M | $365.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $166.1M | $189M | $208M | $249.3M | $275.2M | |
Other Current Liabilities | $55.8M | $84.1M | $77.8M | $65.4M | $140.9M | |
Total Current Liabilities | $883.2M | $1.4B | $1.5B | $1.6B | $1.8B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.6B | $2.2B | $2.5B | $2.9B | $3.3B | |
Common Stock | $626K | $616K | $611K | $606K | $581K | |
Other Common Equity Adj | -$177.2M | -$195.9M | -$252.6M | -$264.3M | -$424.4M | |
Common Equity | $2.6B | $2.7B | $3.1B | $4.2B | $4.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.6B | $2.7B | $3.1B | $4.2B | $4.3B | |
Total Liabilities and Equity | $4.2B | $4.9B | $5.6B | $7.1B | $7.6B | |
Cash and Short Terms | $1.2B | $1.3B | $1.2B | $2.2B | $2B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.2B | $649M | $950.6M | $1.9B | $1.3B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $57M | $78.4M | $107.5M | $126.3M | $141.2M | |
Inventory | $732.9M | $1.3B | $1.6B | $1.3B | $1.7B | |
Prepaid Expenses | $94.8M | $117.7M | $143.1M | $146.7M | $163.7M | |
Other Current Assets | $22.1M | $45.1M | $72M | $34.6M | $28.9M | |
Total Current Assets | $2.3B | $2.3B | $3.1B | $3.8B | $3.6B | |
Property Plant And Equipment | $1.5B | $1.8B | $2.3B | $2.8B | $3.4B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $387.1M | $386.8M | $24M | $24M | $167.4M | |
Other Intangibles | $77.9M | $69.1M | $20.1M | -- | $10.6M | |
Other Long-Term Assets | $87.8M | $113.2M | $132.8M | $167.8M | $203.6M | |
Total Assets | $4.3B | $4.7B | $5.6B | $6.8B | $7.4B | |
Accounts Payable | $196.9M | $308.1M | $287.5M | $261.6M | $304M | |
Accrued Expenses | $182.7M | $268.3M | $254.9M | $274.8M | $354.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $168.1M | $178.3M | $210.5M | $254.4M | $281.8M | |
Other Current Liabilities | $71M | $63.6M | $60M | $74.9M | $101.9M | |
Total Current Liabilities | $964.8M | $1.2B | $1.3B | $1.4B | $1.6B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.7B | $2B | $2.3B | $2.6B | $3.1B | |
Common Stock | $625K | $614K | $610K | $602K | $574K | |
Other Common Equity Adj | -$133.5M | -$216.7M | -$277.6M | -$295.1M | -$336.7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.6B | $2.7B | $3.3B | $4.2B | $4.3B | |
Total Liabilities and Equity | $4.3B | $4.7B | $5.6B | $6.8B | $7.4B | |
Cash and Short Terms | $1.2B | $649M | $950.6M | $1.9B | $1.3B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $588.9M | $975.3M | $854.8M | $1.6B | $1.8B | |
Depreciation & Amoritzation | $185.5M | $224.2M | $291.8M | $379.4M | $446.5M | |
Stock-Based Compensation | $50.8M | $69.1M | $78.1M | $93.6M | $90M | |
Change in Accounts Receivable | -- | -- | -$59M | $6.6M | $1.6M | |
Change in Inventories | -$96.5M | -$323.6M | -$573.4M | $66.6M | -$156.1M | |
Cash From Operations | $803.3M | $1.4B | $966.5M | $2.3B | $2.3B | |
Capital Expenditures | $229.2M | $394.5M | $638.7M | $651.9M | $689.2M | |
Cash Acquisitions | -$452.6M | -- | -- | -- | -$154.1M | |
Cash From Investing | -$695.5M | -$427.9M | -$569.9M | -$654.1M | -$798.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$63.7M | -$812.6M | -$444M | -$558.7M | -$1.6B | |
Other Financing Activities | -$32.4M | -$770K | -$35.2M | -$32.6M | -$35.4M | |
Cash From Financing | -$80.8M | -$845M | -$467.5M | -$548.8M | -$1.7B | |
Beginning Cash (CF) | $1.1B | $1.2B | $1.3B | $1.2B | $2.2B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $27M | $116.2M | -$71M | $1.1B | -$178M | |
Ending Cash (CF) | $1.2B | $1.3B | $1.2B | $2.2B | $2B | |
Levered Free Cash Flow | $574.1M | $994.6M | $327.8M | $1.6B | $1.6B |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $145M | $190M | $290.4M | $321.4M | $314.6M | |
Depreciation & Amoritzation | $50.5M | $64.5M | $84.1M | $95.8M | $114.5M | |
Stock-Based Compensation | $14.9M | $18.4M | $21.3M | $25.8M | $23.1M | |
Change in Accounts Receivable | -- | -- | -- | -$2.6M | -$18.5M | |
Change in Inventories | -$74.2M | -$320.6M | -$155.2M | -$36.4M | -$174.3M | |
Cash From Operations | $214.1M | -$243.3M | $45.5M | $127.5M | -$119M | |
Capital Expenditures | $64.2M | $111.4M | $136.9M | $130.7M | $152.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$85.5M | -$101.3M | -$138.2M | -$131.5M | -$106.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$83.8M | -$232.6M | -$98.5M | -$299.5M | -$434.4M | |
Other Financing Activities | -- | -- | -- | -$32.5M | -$33.8M | |
Cash From Financing | -$122.2M | -$259.6M | -$115.4M | -$328.6M | -$468M | |
Beginning Cash (CF) | $1.2B | $1.3B | $1.2B | $2.2B | $2B | |
Foreign Exchange Rate Adjustment | $22.8M | -$6.7M | $3.9M | -$10.7M | $34.7M | |
Additions / Reductions | $6.4M | -$604.1M | -$208.1M | -$332.6M | -$693.8M | |
Ending Cash (CF) | $1.2B | $649M | $950.6M | $1.9B | $1.3B | |
Levered Free Cash Flow | $149.9M | -$354.6M | -$91.4M | -$3.2M | -$271.2M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $705.2M | $1B | $955.2M | $1.6B | $1.8B | |
Depreciation & Amoritzation | $192.4M | $238.2M | $311.4M | $391M | $465.3M | |
Stock-Based Compensation | $59.6M | $72.6M | $81M | $98M | $87.3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -$48M | -$570M | -$408M | $185.3M | -$294M | |
Cash From Operations | $1.1B | $931.7M | $1.3B | $2.4B | $2B | |
Capital Expenditures | $241.4M | $441.6M | $664.2M | $645.6M | $710.8M | |
Cash Acquisitions | -$452.6M | -- | -- | -- | -$154.1M | |
Cash From Investing | -$735.4M | -$443.8M | -$606.8M | -$647.5M | -$773.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$83.8M | -$961.4M | -$309.8M | -$759.7M | -$1.8B | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$112.4M | -$982.3M | -$323.3M | -$762.1M | -$1.8B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $290.9M | -$494.3M | $325.1M | $968.7M | -$539.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $897.3M | $490.1M | $591M | $1.7B | $1.3B |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $145M | $190M | $290.4M | $321.4M | $314.6M | |
Depreciation & Amoritzation | $50.5M | $64.5M | $84.1M | $95.8M | $114.5M | |
Stock-Based Compensation | $14.9M | $18.4M | $21.3M | $25.8M | $23.1M | |
Change in Accounts Receivable | -- | -- | -- | -$2.6M | -$18.5M | |
Change in Inventories | -$74.2M | -$320.6M | -$155.2M | -$36.4M | -$174.3M | |
Cash From Operations | $214.1M | -$243.3M | $45.5M | $127.5M | -$119M | |
Capital Expenditures | $64.2M | $111.4M | $136.9M | $130.7M | $152.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$85.5M | -$101.3M | -$138.2M | -$131.5M | -$106.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$83.8M | -$232.6M | -$98.5M | -$299.5M | -$434.4M | |
Other Financing Activities | -- | -- | -- | -$32.5M | -$33.8M | |
Cash From Financing | -$122.2M | -$259.6M | -$115.4M | -$328.6M | -$468M | |
Beginning Cash (CF) | $1.2B | $1.3B | $1.2B | $2.2B | $2B | |
Foreign Exchange Rate Adjustment | $22.8M | -$6.7M | $3.9M | -$10.7M | $34.7M | |
Additions / Reductions | $6.4M | -$604.1M | -$208.1M | -$332.6M | -$693.8M | |
Ending Cash (CF) | $1.2B | $649M | $950.6M | $1.9B | $1.3B | |
Levered Free Cash Flow | $149.9M | -$354.6M | -$91.4M | -$3.2M | -$271.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.